← Human Trials & Peer-Reviewed Studies
[The effect of occult hyperprolactinemia (OHP) on gonadotropin secretion system]
Plain-language guide to PMID 7859890 (1994): clinical trial study of TRH (Thyrotropin-Releasing Hormone), hyperparathyroidism.
Key Facts
- PMID
- 7859890
- Journal
- Nihon Naibunpi Gakkai zasshi
- Year
- 1994
- Study type
- Clinical Trial
- Authors
- Aisaka K et al. (8 authors)
- DOI
- 10.1507/endocrine1927.70.10_1101
What This Study Did, in Plain Language
What Was Tested
This clinical trial paper looks at TRH (Thyrotropin-Releasing Hormone) in the context of hyperparathyroidism.
From this result, it was thought that many of the OHP patients were selected in group A.
Who Took Part
PubMed tags the participants as women only.
What Was Measured
The subject headings attached to it are Anovulation, Bromocriptine, Circadian Rhythm, Gonadotropin-Releasing Hormone, Gonadotropins, Hyperprolactinemia and Thyrotropin-Releasing Hormone.
What This Means in Plain Language
This is a clinical trial of TRH (Thyrotropin-Releasing Hormone) in people with hyperparathyroidism.
The publication is from 1994 (Nihon Naibunpi Gakkai zasshi), a journal based in Japan.
More context: the TRH (Thyrotropin-Releasing Hormone) compound page, Hyperparathyroidism research.
Our Notes on the Compound
TRH (Thyrotropin-Releasing Hormone): A 3-amino-acid hypothalamic hormone (protirelin) that triggers TSH and prolactin release.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.